Pfizer appointed Albert Bourla to its Board of Directors

Pfizer claimed the appointment of Albert Bourla, DVM,Ph.D to its Board off Directors with effect from immediately.

Dr.Albert Bourla is currently the Chief operating officer of Pfizer. Prior to this, he was the Group President of Pfizer Innovative Health, accountable for the Consumer Healthcare, Inflammation and Immunology, Internal Medicine, Oncology, Rare Disease and Vaccines business groups.

Dr.Albert Bourla joined Pfizer in 1993, and has held a number of senior global positions in several markets across several disciplines, including: Group President, Global Vaccines, Oncology and Consumer Healthcare business; President and General Manager, Established Products; Area President of Europe, Africa, Middle East, Asia and Pacific, Animal Health; and Vice President, Business Development and New Products, Animal Health.

Dr. Albert Bourla is a doctor of Veterinary Medicine and holds a Ph.D. in Biotechnology of Reproduction from the Veterinary School of Aristotle University. He is a member of the Board of Directors of the Pfizer Foundation and the Biotechnology Innovation Organization (BIO), where he serves on the Executive Committee.